Navigation Links
Omeros to Present Additional OMS302 Clinical Data at the Annual ASCRS and ASOA Symposium and Congress
Date:4/19/2013

SEATTLE, April 19, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that it will present additional data from recent clinical trials evaluating its ophthalmology product, OMS302, at the Annual American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Symposium and Congress taking place in San Francisco April 19-23. The podium presentation, "Effect of an Anti-inflammatory-Mydriatic Agent on the Incidence of Intraoperative Miosis During IOL Replacement Surgery," summarizes key analyses of Phase 2 and Phase 3 clinical data assessing the ability of OMS302 to reduce the incidence of miosis (pupil constriction) during intraoperative lens replacement surgery. These analyses will be included in both the US and European marketing applications for OMS302. Steve Whitaker , M.D., Omeros' vice president of clinical development and chief medical officer, will present the data at 3:27 p.m. PDT on April 21 in the Intraocular Surgery/Medications Session.

About Omeros' OMS302 Program
OMS302 is Omeros' product being developed for use during intraocular lens replacement (ILR), including cataract surgery and refractive lens exchange. OMS302 is a proprietary combination of the mydriatic (pupil dilating) agent phenylephrine and the anti-inflammatory agent ketorolac. Omeros recently completed its successful OMS302 Phase 3 clinical program and expects to submit a New Drug Application to the U.S. Food and Drug Administration this quarter and a Marketing Authorization Application to the European Medicines Agency in mid-2013.

ILR involves replacement of the original lens of the eye with an artificial intraocular lens. These procedures are typically performed to replace a lens opacified by a cataract or to correct a refractive error of the len
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Omeros to Present at Deutsche Bank Securities Health Care Conference
2. Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio
3. Omeros to Present at Jefferies 2012 Global Healthcare Conference
4. Omeros Announces Proposed Public Offering of Common Stock
5. Omeros Prices $30 Million Public Offering of Common Stock
6. Omeros Announces Closing of $34.5 Million Public Offering of Common Stock
7. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
8. Omeros Announces Discovery in MASP-2 Program
9. Omeros Corporation Reports Second Quarter 2012 Financial Results
10. Omeros Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial
11. Omeros to Present at Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 2014 The Brandeis Medical Center, led by Dr. Emmanuel ... and affordable laser tattoo removal experience with the advanced Astanza Duality ... providing high quality cosmetic services with cutting edge medical technology and ... Southern California has seen a dramatic increase in the ...
(Date:1/14/2014)... Emergency Critical Care, a LifeCentre partner practice, located at 165 Fort ... first in Loudoun County to receive a ... M. Barnes , Medical Director, is a well-seasoned veterinarian of more ... , are avid scuba divers. "As altitude skiers and hikers, we ...
(Date:1/14/2014)... , Jan. 14, 2014   Oligomerix, Inc. , a ... therapeutics for Alzheimer,s disease (AD) and related neurodegenerative disorders, ... Valhalla, NY as of January ... space at New York Medical College. Oligomerix, ...
Breaking Medicine Technology:Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
... Sevocity, a division of Conceptual MindWorks, Inc. (CMI), today ... as a preferred electronic health record (EHR) vendor with ... leading true Internet or cloud-based EHR. This enables Sevocity ... health record system with low start-up cost and affordable ...
... STAMFORD, Conn., July 20, 2011 A new online ... healthcare professionals, law enforcement, and community organizations combat the ... Purdue Pharma L.P . has developed RxSafetyMatters.org ... company and organizations with which it is partnering to ...
Cached Medicine Technology:Sevocity® Named Preferred EHR Vendor by CITIA-SC, South Carolina's Health IT Regional Extension Center (REC) 2New Online Resource to Help Combat Abuse of Prescription Medications Launched by Purdue Pharma L.P. 2New Online Resource to Help Combat Abuse of Prescription Medications Launched by Purdue Pharma L.P. 3
(Date:4/23/2014)... that proliferation of endogenous neural precursor cells cannot ... axons. From the perspective of neural plasticity, Dr. ... in China observed the effects of functional electrical ... and expression of basic fibroblast growth factor and ... the infarct side. The researchers found that functional ...
(Date:4/22/2014)... sport in the United States with 1 million participants ... Center for Injury Research and Policy at Nationwide Children,s ... occurrence and distribution patterns of basketball-related injuries treated in ... among adolescents and teens. , The study, published online ... data relating to adolescents 13-19 years of age who ...
(Date:4/22/2014)... A recently FDA-approved device has been shown to reduce ... as 50 percent. When coupled with an innovative electrode ... device facilitated the complete elimination of seizures in nearly ... decade-long clinical trials. , That,s good news for a ... U.S. living with epilepsy whose seizures can,t be controlled ...
(Date:4/22/2014)... can provide primary care for low-income patients may ... insurance companies while improving patient health, researchers have ... that health clinics that avoid costs associated with ... lowering hospital admission rates and emergency room visits, ... State Altoona. , The researchers estimated that ...
(Date:4/22/2014)... are small cell lung cancers (SCLC), which grow ... researchers at Virginia Commonwealth University Massey Cancer Center ... to this resistance that may lead to improved ... B-cell lymphoma 2 (Bcl-2) family proteins, which are ... function, this family of proteins can trigger a ...
Breaking Medicine News(10 mins):Health News:New study finds 2.5 million basketball injuries to high school athletes in 6 seasons 2Health News:New study finds 2.5 million basketball injuries to high school athletes in 6 seasons 3Health News:Newly approved brain stimulator offers hope for individuals with uncontrolled epilepsy 2Health News:Clinics not bogged down by red tape can ease health cost burdens 2Health News:Scientists pinpoint protein that could improve small cell lung cancer therapies 2
... in Making Fatherhood Happen, ATLANTA, June 10 ... had 149,919 new babies born in 2005,the latest year ... many thousands of new mothers, there also were thousands ... becoming a father for the first time," said,fertility expert ...
... antimicrobial coated wristbands helps ... enhance safety, VERNON HILLS, Ill., June 10 ... delivering on-demand,specialty printing solutions for the healthcare industry, has ... printing,easier and more cost-effective for healthcare organizations., "Missing ...
... Researchers are harnessing the powers of digital communications ... the side-effects caused by chemotherapy. , They have ... phones on which the patients can record and send ... managing their care. The phones are capable of giving ...
... London, UK: For Dan Savage, surviving testicular cancer has been ... taking more adventurous decisions, and he says, that in retrospect, it ... him. But as he approaches the end of his fifth year ... as "cured" by the medical profession, he worries that from now ...
... discovered a new way to reduce neuronal loss in the ... loss in people with Alzheimer,s disease can be attributed to ... neuro-toxin Amyloid beta the major component of amyloid plaques ... a specific population of nerve cells in the basal forebrain. ...
... People with irritable bowel syndrome have a higher than usual ... study published tomorrow (Wednesday 11 June). , The research, ... new therapies for the estimated one in five UK adults ... is poorly understood. Symptoms of IBS include abdominal pain, bloating, ...
Cached Medicine News:Health News:Thinking About Being a Father? 2Health News:Zebra Technologies Introduces HC100(TM) Patient I.D. Wristbanding Solution 2Health News:Zebra Technologies Introduces HC100(TM) Patient I.D. Wristbanding Solution 3Health News:Managing symptoms by mobile phone may revolutionize cancer care for young people 2Health News:Managing symptoms by mobile phone may revolutionize cancer care for young people 3Health News:'Cancer was one of the best things to happen to me... but I worry about the future' 2Health News:QBI neuroscientists make Alzheimer's disease advance 2Health News:Common bowel problem linked to chili pepper pain receptor 2
... System is designed to help physicians provide ... leg. Endovenous laser therapy is a patient-friendly ... of varicose veins., In endovenous laser therapy, ... the varicosed vein, generally through a small ...
ELVeS is a new minimally-invasive laser treatment for patients with superficial vein reflux of the greater saphenous vein. The ELVeS laser treatment offers your patients an effective out-patient alt...
Using proven 1064 nm technology for the treatment of deeper lesions, the Lumenis One Multi-Spot Nd:YAG module provides versatility allowing targeted treatment of leg veins, vascular lesions, facial w...
... #1 physician choice in laser treatment, brings ... superficial vein reflux. EVLT is a minimally ... stripping that effectively and safely treats varicose ... occlude the vein. The procedure is easy ...
Medicine Products: